Novel carrier fluids for liquid fungal spore formulations

A liquid formulation using ethoxylated and propoxylated surfactants stabilizes fungal spores at elevated temperatures, addressing viability and effectiveness issues in biological control agents, achieving up to 500% improved germination rates.

JP7579776B2Active Publication Date: 2024-11-08BAYER AG +1
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2021500440
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-07-10
Filing Date
2019-07-10
Publication Date
2024-11-08
Estimated Expiration
2039-07-10

AI Technical Summary

Technical Problem

Existing fungal spore-based biological control agents face challenges in achieving stable formulations that maintain viability and effectiveness at elevated temperatures, particularly due to the sensitivity of fungal spores to environmental factors like water, oxygen, and temperature, and current formulations often require emulsifiers that can be detrimental to spore survival.

Method used

A liquid formulation using ethoxylated and/or propoxylated surfactants, such as ethoxylated fatty acid triglycerides and block copolymers, is developed to stabilize fungal spores at elevated temperatures, ensuring high spore viability and germination rates over extended periods.

Benefits of technology

The formulation maintains spore viability and enhances germination rates by up to 500% compared to control spores, providing a stable and effective biological control agent even at temperatures above 20°C.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007579776000001
    Figure 0007579776000001
  • Figure 0007579776000002
    Figure 0007579776000002
  • Figure 0007579776000003
    Figure 0007579776000003
Patent Text Reader

Abstract

The present invention relates to a liquid preparation comprising at least one ethoxylated and / or propoxylated organic liquid as defined and fungal spores, as well as to a method for controlling phytopathogenic fungi, insects and / or nematodes in or on plants, for enhancing plant growth or for increasing plant yield or root health, which method comprises applying an effective amount of the liquid preparation or liquid composition according to the invention to said plants or to a locus where plants are growing or intended to grow.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] Biological control agents (BCAs) are becoming increasingly important in the field of plant protection to combat various fungal or insect pests or to improve plant health. Mainly bacterial and fungal based BCAs are used in this field, although viruses that can be used as biological control agents are also available. The most prominent forms of fungal based biological control agents are asexual spores called conidia as well as blastospores, but other fungal propagules such as (micro)sclerotia, ascospores, basidiospores, chlamydospores or hyphal fragments may also be promising agents. [Background technology]

[0002] Unlike many bacterial-based spores, such as Bacillus spores, many fungal spores are not very hardy and it has proven difficult to provide fungal spores in a form that meets the requirements of a commercial product, particularly acceptable storage stability at certain temperatures.

[0003] Nonetheless, providing suitable formulations for biocontrol agents still poses a challenge due to the many factors that contribute to the efficacy of the final formulation, such as the properties of the biocontrol agent, temperature stability and shelf life, and the effectiveness of the formulation in application.

[0004] A suitable formulation is a homogeneous, stable mixture of active and inactive ingredients, which makes the final product simpler, safer and more effective to apply to the target.

[0005] Formulations commonly used for biocontrol agents include WP (solid formulations that are micronized into a powder and typically applied as suspended particles after dispersion in water), WG (formulations consisting of granules that are applied after disintegration and dispersion in water). The granules of WG products have well-defined particles in the range of 0.2-4 mm. Water-dispersible granules can be formed by agglomeration, spray drying, or extrusion techniques. Although WP formulations are rather easy to manufacture, they are dusty. Moreover, they are not easy to administer in the field. WG formulations are easier for users to handle and generally have a lower dust content than WP formulations.

[0006] An example of a liquid formulation is an SC (a water-based suspension of a solid active ingredient in a fluid usually intended to be diluted with water before use). Another liquid formulation type is an EC (a solution of the active ingredient in combination with a surfactant such as an emulsifier in a water-insoluble organic solvent that forms an emulsion when added to water).

[0007] A vast number of formulations are utilized in experimental and commercial formulations of biocontrol agents (for a more detailed description and listing, see Schisler et al., Phytopathology, Vol. 94, No. 11, 2004). In general, formulations can be classified as either carriers (fillers, extenders) or formulations that improve the chemical, physical, physiological or nutritional properties of the formulated biomass.

[0008] Stability, especially storage stability of BCA based on fungal activity over extended periods at or above room temperature, is particularly challenging due to the delicate nature of fungal conidia. Like many organisms, dormant fungal conidia are sensitive to environmental influences, e.g., water, air (oxygen), temperature, and irradiation. Some factors can induce germination, while others can have a detrimental effect on spore viability. To exclude water, oils such as white mineral (paraffinic) or vegetable oils are typically used to prepare liquid fungal spore formulations. While many of these oils provide some shelf life for fungal organisms, oil-based preparations require emulsifiers, which often have a detrimental effect on spore viability over extended periods and / or elevated temperatures.

[0009] Examples of biocontrol agent formulations are described in Torres et al., 2003, J Appl Microbiol, 94(2), pp:330-9. However, it is clear that a formulation that preserves the viability of a biocontrol agent, such as a fungal spore, at more than 70% for 4 months at 4°C is not suitable for routine use in the field. Rather, it is desirable for the biocontrol agent formulation to have a sufficient shelf life even under conditions where refrigeration is not possible.

[0010] Kim et al., 2010 (J.S.K. Kim, Y.H. Je, J.Y. Roh, Journal of Industrial Microbiology & Biotechnology 2010, vol.37 (issue 4), pp.419ff) discloses that conidia of the fungus Isaria fumosorosea when dispersed in oil (soybean, corn, cottonseed, paraffin oil, methyl oleate) show improved shelf life at 50°C for 2 and 8 hours compared to dispersions in water.

[0011] Mbarga et al., 2014 (Biological Control 2014, vol. 77, pp. 15ff) found that Trichoderma asperellum formulated in soybean oil containing different emulsifiers showed improved shelf life compared to dispersions of conidia in water.

[0012] Other liquids such as ethoxylated trisiloxanes (e.g., Break-Thru S240) are suitable alternatives and provide stable formulations, for example with P. Lilacinum (BioAct®, see WO 2016 / 050726), however, the production of such trisiloxanes, and thus the product itself, is expensive.

[0013] Oil suspensions containing fungal spores are known in the art. Typical examples of oils used for such purposes are, for example, vegetable oils, paraffin oils or aromatic hydrocarbons. WO2015 / 069708A1 describes a liquid formulation of microorganisms based on paraffin oil with up to 35% of emulsifier, which leaves less residue on plastic surfaces. US2007 / 0141032A1 describes a formulation of microorganisms based on paraffin oil containing a drying agent and up to 10% of emulsifier.

[0014] US20140143909A1 describes the general use of surfactants as "optional ingredients" or co-formulants in liquid or solid compositions containing fungal spores.

[0015] Surfactants are further used in aqueous preparations. For example, US2006 / 0247150 and US2011 / 0033436A1 describe water-based formulations that also contain microorganisms and various nonionic, anionic, cationic and amphoteric surfactants. [Prior art documents] [Patent documents]

[0016] [Patent Document 1] WO2016 / 050726 [Patent Document 2] WO2015 / 069708A1 [Patent Document 3] US2007 / 0141032A1 [Patent Document 4] US20140143909A1 [Patent Document 5] US2006 / 0247150 [Patent Document 6] US2011 / 0033436A1 [Non-patent literature]

[0017] [Non-Patent Document 1] Schisler et al., Phytopathology, Vol94, No.11,2004 [Non-Patent Document 2] Torres et al., 2003, J Appl Microbiol, 94(2), pp:330-9 [Non-Patent Document 3] Kim et al., 2010 (JSKim, YHJe, JYRoh, Journal of Industrial Microbiology & Biotechnology 2010, vol37(issue4), pp.419ff) [Non-Patent Document 4] Mbarga et al., 2014(Biological Control 2014,vol.77,pp.15ff) Summary of the Invention [Problem to be solved by the invention]

[0018] Due to the above-mentioned shortcomings, there remains a need for simple, easy-to-handle formulations for biocontrol agents based on fungal active substances. Among other properties, such formulations ideally provide good physical stability in the formulation concentrate, exhibit a suitable shelf life over time, especially at high temperatures (above 20°C), and provide good water miscibility or suspendability. [Means for solving the problem]

[0019] As mentioned above, there is very little preference that organic fluids other than oil or organosilicon can be used to provide a stable agrochemical formulation of fungal spore-based BCA. Ethoxylated and / or propoxylated surfactants are known to have emulsifying properties, and therefore these compounds are frequently used as emulsifiers using typical amounts. Surprisingly, it has been found that a number of different ethoxylated and / or propoxylated ethoxylated fluids provide good to excellent spore viability after storage at high temperatures (30°C and above for 8 weeks) when used as the main carrier.

[0020] Thus, in a first aspect, the present invention provides a method for producing a method for treating a pulmonary arthritis a) an ethoxylated fatty acid triglyceride having 3 to 10 ethylene oxide units, wherein said fatty acid triglyceride is selected from the group consisting of castor oil and vegetable oil; b) General formula: [ka]

[0021] wherein a1, a2 and b independently have an average value of 1 to 10; or a1 and a2 independently have an average value of 1 to 20 and b has an average value of 15 to 35; and c) General formula: [ka]

[0022] wherein X and Y are independently selected from hydrogen, branched or linear alkyl having 1 to 24 carbon atoms, and branched or linear carbonyl having 2 to 24 carbon atoms, saturated or partially unsaturated, and optionally bearing hydroxyl functionality; m is an average number between 0 and 10; n is an average number from 0 to 40, preferably from 0 to 30, more preferably from 0 to 20, most preferably from 0 to 15, even more preferably from 0 to 10, and m+n is not zero. or at least one ethoxylated and / or propoxylated organic liquid selected from the group consisting of or a mixture of any one of a) to c); and fungal spores The present invention relates to a liquid preparation comprising:

[0023] Fungal spores within the scope of the present invention include asexual spores, called conidia, and blastospores, but also other fungal propagules such as ascospores, basidiospores, chlamydospores, etc. (Micro)sclerotia are not spores in the strict sense, but may also be added to the liquid preparations according to the invention.

[0024] The mixture of any one of a) and b) can be present in a ratio ranging from 1:100 to 100:1, preferably in a ratio ranging from 1:50 to 50:1, more preferably in a mixture ranging from 1:25 to 25:1, such as 1:20, 1:15, 1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1, 15:1 or 20:1. Yet another preferred embodiment comprises a mixture of any one of a) and b) in a ratio ranging from 1:20 to 1:1, or in a ratio ranging from 1:1 to 20:1.

[0025] The mixture of any one of a) and c) can be present in a ratio ranging from 1:100 to 100:1, preferably in a ratio ranging from 1:50 to 50:1, more preferably in a mixture ranging from 1:25 to 25:1, such as 1:20, 1:15, 1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1, 15:1 or 20:1. Yet another preferred embodiment comprises a mixture of any one of a) and c) in a ratio ranging from 1:20 to 1:1, or in a ratio ranging from 1:1 to 20:1.

[0026] The mixture of any one of b) to c) can be present in a ratio ranging from 1:100 to 100:1, preferably in a ratio ranging from 1:50 to 50:1, more preferably in a mixture ranging from 1:25 to 25:1, such as 1:20, 1:15, 1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1, 15:1 or 20:1. Yet another preferred embodiment comprises a mixture of any one of b) and c) in a ratio ranging from 1:20 to 1:1, or in a ratio ranging from 1:1 to 20:1.

[0027] The mixture of any one of a) and b) and c) may be in a ratio in the range of 1:1:100 to 100:100:1, or 1:100:1 to 100:1:100, or 100:1:1 to 1:100:100, preferably in a ratio in the range of 1:1:50 to 50:50:1, or 1:50:1 to 50:1:50, or 50:1:1 to 1:50:50, more preferably in a ratio in the range of 1:1:25 to 25:25:1, or 1:25:1 to 25:1:25, or 25:1:1 to 1:25:25, e.g. It can be present in the following formats: 20:1, 1:15:1, 1:10:1, 1:5:1, 1:1:1, 20:1:1, 15:1:1, 10:1:1, 5:1:1, 1:1:20, 1:1:15, 1:1:10, 1:1:5, 5:20:1, 5:15:1, 5:10:1, 1:20:5, 1:15:5, 1:10:5, 20:1:5, 15:1:5, 10:1:5, 20:5:1, 15:5:1, 10:5:1, 1:5:20, 1:5:15, 1:5:10, 5:1:20, 5:1:15 or 5:1:10. Yet another preferred embodiment comprises a mixture of any one of a) and b) and c) in a ratio ranging from 1:20:1 to 1:1:1, or in a ratio ranging from 20:1:1 to 1:1:1, or in a ratio ranging from 1:1:20 to 1:1:1.

[0028] Preferably the fungal spores are conidia.

[0029] In a preferred embodiment, said ethoxylated fatty acid triglycerides according to a) are derived from a vegetable oil selected from the group consisting of sunflower oil, rapeseed oil, soybean oil, corn oil, coconut oil and palm oil, the composition of which can be found at http: / / www.dgfett.de / material / fszus.php.

[0030] In another preferred embodiment, the ethoxylated fatty acid triglycerides according to a) are derived from castor oil. Selected examples of ethoxylated castor oils are particularly preferred, for example Lucramul CO08 (Castor oil ethoxylate 8EO) and Etocas 10 (Castor oil ethoxylate 10EO).

[0031] Concerning said ethoxylated and propoxylated organic liquids according to b), this is preferably selected from the group consisting of block copolymers of formula HO-[CH2-CH2-O-]a1-[CH2-CH(CH3)-O]b-[CH2-CH2-O-]a2-H, in which a1 and a2, independently of one another, have an average value between 1 and 20 and b has an average value between 15 and 35. More preferably, said ethoxylated and propoxylated organic liquids are selected from the group of block copolymers in which a1 and a2, independently of one another, have an average value between 1 and 16 and b has an average value between 20 and 30. Said ethoxylated and propoxylated organic liquids according to b) preferably have an average molar weight between about 1000 and about 3000 g / mol, more preferably between about 1500 g / mol and about 3000 g / mol, more preferably between about 2000 g / mol and about 3000 g / mol.

[0032] For example, for block copolymers in which the average values ​​of a1 and a2 are 3-16 and the average value of b is 25-35, the average molecular weight may be in the range of about 2000 to about 3000 g / mol. For block copolymers in which the average values ​​of a1 and a2 are 2-12 and the average value of b is 15-25, the average molecular weight may be in the range of about 1400 to about 2200 g / mol. For block copolymers in which the average values ​​of a1 and a2 are 1-12 and the average value of b is 10-20, the average molecular weight may be in the range of about 1000 to about 2000 g / mol.

[0033] Selected examples of ethoxylated and propoxylated organic liquids according to b) are represented by Synperonic PE / L62, Synperonic PE / L64 and Synperonic PE / L44 which are particularly preferred.

[0034] In another embodiment, the ethoxylated and propoxylated organic liquids according to b) are preferably selected from the group consisting of block copolymers of formula HO-[CH2-CH2-O-]a1-[CH2-CH(CH3)-O]b-[CH2-CH2-O-]a2-H, where a1, a2 and b, independently of one another, have an average value of 1 to 8. More preferably, said block copolymers have an average amount of 2 to 8 propylene oxide units and 2 to 12 ethylene oxide units, where a1 and a2, independently of one another, may have a value in total not exceeding 12. Even more preferably, said block copolymers have an average amount of 2 to 6 propylene oxide units and 2 to 8 ethylene oxide units, where a1 and a2, independently of one another, may have a value in total not exceeding 8.

[0035] In this embodiment, the ethoxylated and propoxylated organic liquids according to b) preferably have an average molar mass of from about 150 to about 1500 g / mol, more preferably from about 150 g / mol to about 1200 g / mol, more preferably from about 200 g / mol to about 1000 g / mol, and even more preferably from about 200 to about 700 g / mol.

[0036] For example, when the average values ​​of a1, a2 and b are independently 1 to 10, the average molecular weight may range from about 150 to about 1500 g / mol. When the average values ​​of a1, a2 and b are independently 1 to 8, the average molecular weight may range from about 150 to about 1200 g / mol. For block copolymers having an average amount of 2 to 8 propylene oxide units and 2 to 12 ethylene oxide units (wherein a1 and a2 may independently have a value not exceeding 12 in total), the average molecular weight may range from about 200 g / mol to about 1000 g / mol. For block copolymers having an average amount of 2 to 6 propylene oxide units and 2 to 8 ethylene oxide units (wherein a1 and a2 may independently have a value not exceeding 8 in total), the average molecular weight may range from about 200 to about 700 g / mol.

[0037] In this embodiment, it is most preferred that in said ethoxylated and propoxylated organic liquids according to b), a1 and a2 independently of each other have a value of 1-4 and b has a value of 2-6.

[0038] In a preferred embodiment, in the polymer of c), X is a branched or linear alkyl having 1-18 carbon atoms, or a branched or linear carbonyl having 2-18 carbon atoms, saturated or partially unsaturated, and Y is hydrogen, or a branched or linear alkyl having 1-6 carbon atoms, or a branched or linear carbonyl having 2-6 carbon atoms, saturated or partially unsaturated. For clarity, the skilled artisan knows that branched alkyl or carbonyl groups can only be present with at least 3 carbon atoms.

[0039] In an alternative preferred embodiment, in the polymer of c), X is hydrogen, or a branched or linear alkyl having 1-6 carbon atoms (for clarity throughout this application, the branched portion must have at least 3 carbon atoms), or a branched or linear carbonyl having 2-6 carbon atoms, saturated or partially unsaturated, optionally with a hydroxyl functionality, and Y is a branched or linear alkyl having 1-18 carbon atoms, or a branched or linear carbonyl having 2-18 carbon atoms, saturated or partially unsaturated, optionally with a hydroxyl functionality. In a preferred embodiment, in the polymer of c), m+n is 1-30, more preferably 1-20, most preferably 1-15. In an alternative preferred embodiment, m is in the range of 1-9 and n is in the range of 0-6, or m is in the range of 0-5 and n is in the range of 3-10. In yet another preferred embodiment, m is in the range of 1-5, where n is equal to zero, or n is in the range of 4-10, where m is equal to zero.

[0040] In the above, carbonyl refers to alkylcarbonyl, alkenylcarbonyl, or alkynylcarbonyl as defined below.

[0041] As shown in the examples of the present application, it has been found that fluids with a fairly low molecular weight still have the stabilizing effect according to the present invention, while other structurally similar fluids with a fairly low molecular weight do not show this effect. Although the applicant does not wish to be bound by any scientific theory, it is believed that certain structural motifs of fluids, such as a combination of a fairly small alkyl chain with a certain number of ethylene oxide units, are not suitable for stabilizing fungal spores and lead to the opposite result. Surprisingly, this behavior is not observed when the very same small alkyl chain is combined with a certain number of propylene oxide units. Thus, in another preferred embodiment, in the polymer of c), when m is equal to zero, the molecular weight (MW) of said at least one ethoxylated organic liquid is 190 mass units or more, more preferably 205 mass units or more, even more preferably 220 mass units or more, for example at least 235 mass units.

[0042] Although the skilled person will be able to define which liquids fall within the scope of the present invention, ethoxylated and / or propoxylated organic liquids according to c) above are polyethylene glycols, such as Pluriol E300 (polyethylene glycol-300); ethoxylated alcohols, such as Atplus 245 (alcohol ethoxylate), Berol 050 (linear C12-C16 ethoxylated alcohol, 3EO), Berol 260 (C9-C11 ethoxylated alcohol, 4EO), Ecosurf EH3 (triethylene glycol-monooctyl ether), Lucramul L03 (C12-C18 ethoxylated alcohol, 3EO), Lucramul L05 (C12-C18 ethoxylated alcohol, 5EO), Lutensol AO3 (C13-15-branched and linear ethoxylated alcohol, 3EO), Lutensol AO7. (C13-15-branched and linear ethoxylated alcohols, 7EO), triethylene glycol monobutyl ether; mono- / polyethylene oxide diethers, such as Tetraglyme (tetraethylene glycol diether); mono- / polyethylene oxide ether-esters, such as Arlatone TV (sorbitol-heptaoleate, 40EO), n-butyl diglycoacetate, Tween 20 (ethoxylated sorbitol monolaurate, 20EO), Tween-80 (ethoxylated sorbitol monooleate, 20EO), Tween-85 (ethoxylated sorbitol monooleate, 20EO); ethoxylated carboxylic acids, such as Alkamuls A (polyethylene glycol monooleate), Radiasurf 7402 (polyethylene glycol-200 monooleate), Radiasurf 7423 (polyethylene glycol-400 monolaurate); mono- / polyethylene oxide diesters, such as Radiasurf 7442 (polyethylene glycol-400 dioleate); polypropylene glycols, such as dipropylene glycol; propoxylated alcohols, such as Dowanol DPM (dipropylene glycol monomethyl ether); mono- / polypropylene oxide diethers, such as dipropylene glycol dimethyl ether;Preferably, the ester is selected from the group consisting of mono / polypropylene oxide ether esters, such as dipropylene glycol methyl ether acetate; propoxylated carboxylic acids; mono / polypropylene oxide diesters, such as propylene glycol diacetate; alcohol propoxylate-ethoxylates, such as Atlas G-5002L (alcohol propoxylate-ethoxylate), Lucramul HOT 5902 (alcohol propoxylate-ethoxylate), carboxylic acid propoxylate-ethoxylate; carboxylic acid propoxylate-ethoxylate ethers, such as Leofat OC0503M (fatty acid, propoxylated-ethoxylated, end-capped methyl fatty acid, propoxylated-ethoxylated, end-capped methyl);

[0043] In another preferred embodiment, and in addition to the above, the ethoxylated alcohols butyl carbitol, butyl cellosolve, hexyl cellosolve, methoxy triglycol and propyl cellosolve are not within the scope of the liquid according to c).In the course of the present invention, it has surprisingly been found that certain liquids as defined herein are suitable for increasing the storage stability of fungal spores.In other words, the fungal spores present in the liquid formulation according to the present invention show improved germination rate after a given time compared to the fungal spores present in different formulations or in pure form.

[0044] Unless otherwise indicated, the term "%" as used throughout this application relates to % by weight (wt.).

[0045] In the context of the present invention, "improved germination rate" refers to the germination rate of dormant fungal structures or organs, preferably fungal spores, which at least 2 weeks after the production of the spores, after the end of the cooling period, is at least 10% higher, preferably at least 20%, more preferably at least 30% or at least 40%, and most preferably at least 50% higher than the germination rate of dormant fungal structures or organs, such as spores that have not been treated according to the procedure of the present invention but are otherwise treated equally ("control spores"). In other words, "improved germination rate" means a germination rate that is at least 110%, preferably at least 120%, more preferably at least 130% or at least 140%, most preferably at least 150% or more than the germination rate of control spores at least 2 weeks after the production of the spores. Preferably, the improved germination rate remains visible or even increases at least 3 months, more preferably at least 4 months, most preferably at least 6 months, such as at least 8 months, at least 10 months, or even 12 months or more after production. Therefore, the germination rate of the spores treated according to the present invention is preferably at least 200% of the germination rate of the control spores 3 months after the production of said spores.In another preferred embodiment, the germination rate is at least 300% or at least 400%, most preferably at least 500% of the germination rate of the control spores 6 months after the production of said spores.In this context, the germination rate indicates the ability of the spores to still germinate after a given time.Therefore, the % germination rate means the proportion of spores that can germinate after a given period of time.The method of measuring the germination rate is well known in the art.For example, spores are spread on the surface of an agar medium and the percentage of spores that develop mycotubes is determined microscopically after incubation at an appropriate growth temperature (Oliveira et al., A protocol for determination of conidial viability of the fungal entomopathogens Beauveria bassiana and Metarhizium anisopliae from commercial products. Journal of Microbiological Methods 119; pp: 44-52, and references therein).

[0046] In certain embodiments, the present invention provides: 0.1-40%, preferably 2.5-30%, most preferably 5-25%, for example 10-20% fungal spores; up to 99.9%, preferably 70 to 97.5%, most preferably 75 to 95%, for example 80 to 90%, of an ethoxylated and / or propoxylated organic liquid as defined above, 0-10%; preferred 0-8%, most preferred 0.1-5% surfactants (e.g., dispersants and emulsifiers); 0-10%, preferably 0-7%, more preferably 0.5-5% of a rheology modifier, such as fumed silica, attapulgite; 0-5%, preferably 0-3%, most preferably 0.1-0.5% of each of the following: antifoaming agents, antioxidants, dyes The present invention provides a liquid formulation comprising:

[0047] Unless otherwise defined, the term "alkyl" refers to saturated straight-chain or branched hydrocarbon groups, such as (C1-C18)-, (C1-C6)-, or (C1-C4)-alkyl. Examples: methyl, ethyl, propyl, 1-methylethyl, butyl, and the like.

[0048] Examples (but not limited to): (C1-C6)-alkyl, such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2 dimethylpropyl, 1-ethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Unless otherwise defined, the term "alkenyl" refers to an unsaturated straight or branched hydrocarbon group containing at least one double bond, such as (C2-C18)-, (C2-C6)- or (C2-C4)-alkenyl, e.g., ethenyl, 1-propenyl, 3-butenyl, etc. Examples (but not limited to): (C2-C6)-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl 2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, and 1-ethyl-2-methyl-2-propenyl. Unless otherwise defined, the term "alkoxy" (alkyl-O-) refers to an alkyl group attached to the scaffold via an oxygen atom (-O-), e.g., (C1-C18)-, (C1-C6)- or (C1-C4)-alkoxy. Examples: methoxy, ethoxy, propoxy, 1-methylethoxy, etc. Examples (but not limited to): (C1-C6)-alkoxy, such as methoxy, ethoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2 -Methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy. Similarly, unless otherwise defined, the terms "alkenoxy" and "alkynoxy" refer to an alkenyl or alkynyl group, respectively, attached to the scaffold via -O-, such as (C2-C18)-, (C2-C6)- or (C2-C4)-alkenoxy, or (C3-C10)-, (C3-C6)- or (C3-C4)-alkynoxy, respectively.

[0049] Unless otherwise defined, the term "alkylcarbonyl" (alkyl-C(=O)-) refers to an alkyl group attached to the scaffold via -C(=O), e.g., (C1-C18)-, (C1-C6)- or (C1-C4)-alkylcarbonyl. The number of C atoms therefore refers to the alkyl group within the alkylcarbonyl group. Similarly, unless otherwise defined, the terms "alkenylcarbonyl" and "alkynylcarbonyl" refer to an alkenyl or alkynyl group, respectively, attached to the scaffold via -C(=O), such as (C2-C18)-, (C2-C6)- or (C2-C4)-alkenylcarbonyl, or (C2-C10)-, (C2-C6)- or (C2-C4)-alkynylcarbonyl, respectively. The number of C atoms therefore refers to the alkenyl or alkynyl group, respectively, within the alkenylcarbonyl or alkynylcarbonyl group.

[0050] Unless otherwise defined, the term "alkoxycarbonyl" (alkyl-OC(=O)-) refers to an alkyl group attached to the scaffold via -OC(=O), e.g., (C1-C18)-, (C1-C6)- or (C1-C4)-alkoxy-carbonyl. The number of C atoms therefore refers to the alkyl group within the alkoxycarbonyl group.

[0051] Similarly, unless otherwise defined, the terms "alkenoxycarbonyl" and "alkynoxycarbonyl" refer to an alkenyl or alkynyl group, respectively, attached to the scaffold via -OC(=O), such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenoxycarbonyl, or (C3-C10)-, (C3-C6)- or (C3-C4)-alkynoxycarbonyl, respectively. The number of C atoms therefore refers to the alkenyl or alkynyl group, respectively, within the alkenoxycarbonyl or alkynoxycarbonyl group.

[0052] Unless otherwise defined, the term "alkylcarbonyloxy" (alkyl-C(=O)-O-) refers to an alkyl group attached to the scaffold via -C(=O)-O-, e.g., (C1-C10)-, (C1-C6)- or (C1-C4)-alkylcarbonyloxy. Thus, the number of C atoms refers to the alkyl group within the alkylcarbonyloxy group. Similarly, unless otherwise defined, the terms "alkenylcarbonyloxy" and "alkynylcarbonyloxy" refer to an alkenyl or alkynyl group, respectively, attached to a scaffold via -C(=O)-O, such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenylcarbonyloxy or (C2-C10)-, (C2-C6)- or (C2-C4)-alkynylcarbonyloxy, respectively. The number of C atoms therefore refers to the alkenyl or alkynyl group, respectively, within the alkenylcarbonyloxy or alkynylcarbonyloxy group.

[0053] In a preferred embodiment, the composition according to the invention is essentially free of water. BCAs are living organisms in a dormant form. Thus, formulations with low concentrations of water or essentially free of water are preferred formulation types for BCAs. On the other hand, certain BCAs may also be formulated with higher water contents. When water is present, such water is mainly derived from residual free water in the dried spore powder or trace amounts of water in other formulations. Thus, due to these facts, water concentrations of 0-12% by weight, preferably 0-8% by weight, are possible, this range falling within the definition of "essentially free of water". In other words, the term "essentially free of water" means that the concentration of water in the composition is 12% or less, preferably 8% by weight or less. More preferably, the water concentration is in the range of 0-6% by weight, more preferably 0-4% by weight, for example 2-4% by weight. Thus, exemplary water concentrations include 2% by weight, 3% by weight, 4% by weight, 5% by weight, and 6% by weight.

[0054] In liquid formulations according to the invention, the ethoxylated and / or propoxylated organic liquid is preferably present in an amount of at least 50% by weight, although it is contemplated that the ethoxylated and / or propoxylated organic liquid may be present in lesser amounts, for example at least 40% by weight. Generally, the ethoxylated and / or propoxylated organic liquid may be present in a concentration in the range of up to 99.9% by weight, preferably from 70% to 97.5% by weight, more preferably from 75% to 95% by weight, and most preferably from 80% to 90% by weight.

[0055] The liquid preparation according to the invention is preferably water-miscible. The term "water-miscible" indicates that the liquid gives rise to a homogenous mixture when combined with water in a ratio of 1:200, preferably 1:100, more preferably 1:50.

[0056] In one preferred embodiment, the composition is essentially oil-free. In the context of the present invention, oil is defined as any liquid that is essentially not water-miscible or not self-emulsifiable in water, such as paraffin oil, fatty acid triglycerides, fatty acid monoesters, certain silicone oils, aromatic solvents or other water-immiscible organic solvents. The term "essentially oil-free" refers to an oil content of 5% by weight or less, preferably 4% by weight or less, even more preferably 3% by weight or less, most preferably 2% by weight or less, such as 1% by weight, 0.1% by weight, 0.05% by weight, or even 0.01% by weight. Due to the manufacturing process of its components, it cannot be excluded that the composition of the present invention contains traces of oil. The formulation of the present invention does not contain oil except for such traces.

[0057] Any fungal species can be applied to the present invention. However, it is preferred that the fungal spore is derived from a fungal species that has a beneficial effect on plants, such as a fungal species that is effective as a biological control agent in plant protection or that acts as a plant health promoter, such as supporting or promoting plant growth and / or plant health. More preferably, the fungus is a filamentous fungus.

[0058] Filamentous fungi, as is well known in the art, are distinguished from yeasts by their tendency under most conditions to grow in a multicellular, filamentous form, as opposed to the unicellular growth of primarily oval or elliptical yeast cells.

[0059] The at least one filamentous fungus may be any fungus that has a positive effect on the plant, such as a plant-protecting or plant-growth-promoting effect. Thus, the fungus may be an entomopathogenic fungus, a nematophagous fungus, a plant-growth-promoting fungus, a fungus active against plant pathogens, such as bacterial or fungal plant pathogens, or a fungus with herbicidal activity.

[0060] NRRL is the abbreviation for the Agricultural Research Service Culture Collection, an international depository institution for the purpose of depositing microbial strains under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, and is located at the National Center for Agricultural Utilization Research, Agricultural Research Service, USDA Department of Agriculture, 1815 North University Street, Peroira, Illinois 61604, USA.

[0061] ATCC is an abbreviation for American Type Culture Collection, an international depository for the purpose of depositing microbial strains under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, and has the address of ATCC Patent Depository, 10801 University Blvd., Manassas, VA 10110 USA.

[0062] Only a few fungi with selective herbicidal activity are known, for example F2.1 Phoma macrostroma, in particular strain 94-44B; F2.2 Sclerotinia minor, in particular strain IMI 344141 (e.g. Sarritor by Agrium Advanced Technologies); F2.3 Colletotrichum gloeosporioides, in particular strain ATCC 20358 (e.g. Collego (also known as LockDown) by Agricultural Research Initiatives); F2.4 Stagonospora atriplicis; or F2.5 Fusarium oxysporum, different strains of which are active against different plant species, for example the weed Striga hermonthica (Fusarium oxysproum formae specialis strigae).

[0063] Exemplary species of fungi that support, promote or stimulate plant growth / health are: E2.1 Talaromyces flavus, in particular strain V117b; E2.2 Trichoderma atroviride, in particular strain CNCM I-1237 (e.g. Esquive® WP from Agrauxine, FR), strain SC1 described in International Application No. PCT / IT2008 / 000196, strain number V08 / 002387, strain number NMI number V08 / 002388, strain number NMI number V08 / 002389, strain number NMI number V08 / 002390, strain LC52 (e.g. Sentinel from Agrimm Technologies Limited), strain kd (e.g. T-Gro from Andermatt Biocontrol), and / or strain LUI32 (e.g. Tenet from Agrimm Technologies Limited); E2.3 Trichoderma E2.4 Myrothecium verrucaria, in particular strain AARC-0255 (e.g. DiTera® from Valent Biosciences); E2.5 Penicillium bilaii, in particular strain ATCC 22348 (e.g. JumpStart® from Acceleron BioAg) and / or strain ATCC20851; E2.6 Pythium oligandrum, in particular strain DV74 or strain M1 (ATCC 38472; e.g. Polyversum from Bioprepraty, CZ); E2.7 Rhizopogon amylopogon (e.g. in Myco-Sol from Helena Chemical Company); E2.8 Rhizopogon fulvigleba (e.g. in Myco-Sol from Helena Chemical Company); E2.9 Trichoderma harzianum, especially strain TSTh20, strain KD, especially the product Eco-T from Plant Health Products, ZA, or strain 1295-22; E2.10 Trichoderma koningii; E2.11 Glomus aggregatum;E2.12 Glomus clarum;E2.13 Glomus deserticola;E2.14 Glomus etunicatum;E2.15 Glomus intraradices;E2.16 Glomus monosporum;E2.17 Glomus mosseae;E2.18 Laccaria bicolor;E2.19 Rhizopogon luteolus;E2.20 Rhizopogon tinctorus;E2.21 Rhizopogon villosulus;E2.22 Scleroderma cepa;E2.23 Suillus granulatus;E2.24 Suillus punctatapies;E2.25 Trichoderma virens, especially strain GL-21; and E2.26 strain Verticillium albo-atrum (formerly V. dahliae), especially strain WCS850 (CBS 276.92; e.g. Dutch Trig from Tree Care Innovations); E2.27 Trichoderma viride, e.g. strain B35 (Pietr et al., 1993, Zesz.Nauk.AR w Szczecinie 161:125-137) and E2.28 Purpureocillium lilacinum (formerly known as Paecilomyces lilacinus) strain 251 (AGAL 89 / 030550; e.g. BioAct from Bayer CropScience Biologics GmbH).

[0064] In a more preferred embodiment, the fungal strain having a beneficial effect on plant health and / or growth is selected from Talaromyces flavus, strain VII7b; Trichoderma harzianum strain KD or the strain in the product Eco-T (Plant Health Products, SZ); Myrothecium verrucaria, in particular strain AARC-0255; Penicillium bilaii, strain ATCC22348; and Pythium oligandrum, strain DV74 or strain M1 (ATCC 38472); Trichoderma viride strain B35; Trichoderma atroviride strain CNCM I-1237; and Purpureocillium lilacinum (formerly known as Paecilomyces lilacinus) strain 251 (AGAL 89 / 030550).

[0065] In an even more preferred embodiment, the fungal strain having a beneficial effect on plant health and / or growth is selected from Penicillium bilaii strain ATCC 22348, Trichoderma viride, e.g. strain B35, Trichoderma atroviride, strain CNCM I-1237 and Purpureocillium lilacinum (formerly known as Paecilomyces lilacinus) strain 251 (AGAL 89 / 030550).

[0066] Bactericidally active fungi are, for example, A2.2 Aureobasidium pullulans, in particular blastospores of the strain DSM 14940; A2.3 Aureobasidium pullulans, in particular blastospores of the strain DSM 14941 or a mixture of blastospores of the strains DSM 14940 and DSM 14941; A2.9 Scleroderma citrinum.

[0067] Fungi active against fungal pathogens are, for example: B2.1 Coniothyrium minitans, in particular the strain CON / M / 91-8 (accession number DSM-9660; e.g. Contans® from Bayer CropScience Biologics GmbH); B2.2 Metschnikowia fructicola, in particular the strain NRRL Y-30752; B2.3 Microsphaeropsis ochrace, in particular the strain P130A (ATCC deposit 74412); B2.4 Muscodor albus, in particular the strain QST 20799 (accession number NRL30547); B2.5 Trichoderma harzianum rifai, in particular the strain KRL-AG2 (also known as strain T-22, / ATCC 208479, e.g. PLANTSHIELD T-22G, Rootshield®, and TurfShield from BioWorks, US) and T39 strains (Trichodex® from Makhteshim, US); B2.6 Arthrobotrys dactyloides; B2.7 Arthrobotrys oligospora; B2.8 Arthrobotrys superba; B2.9 Aspergillus flavus, especially strain NRRL 21882 (e.g., Afla-Guard® from Syngenta) or strain AF36 (e.g., AF36 from Arizona Cotton Research and Protection Council, US); B2.10 Gliocladium rosea (also known as Clonostachys rosea f. rosea), especially strain 321U from Adjuvants Plus, Xue (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling root tot complex of field pea, Can Jour Plant Sci 83(3): 519-524) and the ACM941 and IK726 strains (Jensen DF et al., .Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea strain 'IK726'; Australas Plant Pathol. 2007;36:95-101), strain 88-710 (WO2007 / 107000), strain CR7 (WO2015 / 035504) or strains CRrO, CRM and CRr2 (disclosed in WO2017109802); B2.11 Phlebiopsis (or Phlebia or Peniophora) gigantea, in particular strains VRA 1835 (ATCC 90304), VRA 1984 (DSM16201), VRA 1985 (DSM16202), VRA 1986 (DSM16203), FOC PG strain B20 / 5 (IMI390096), strain FOC PG SP log6 (IMI390097), strain FOC PG SP log5 (IMI390098), strain FOC PG BU3 (IMI390099), strain FOC PG BU4 (IMI390100), strain FOC PG 410.3 (IMI390101), strain FOC PG 97 / 1062 / 116 / 1.1 (IMI390102) strain FOC PG B22 / SP1287 / 3.1 (IMI390103), strain FOC PG SH1 (IMI390104) and / or strain FOC PG B22 / SP1190 / 3.2 (IMI390105) (Phlebiopsis products are available from e.g. Verdera and FIN. Rotstop®, PG-Agromaster®, PG-Fungler®, PG-IBL®, PG-Poszwald® and Rotex® from e-nema, DE; B2.12 Pythium oligandrum, in particular strain DV74 or M1 (ATCC 38472; e.g. Polyversum from Bioprepraty, CZ); B2.13 Scleroderma citrinum; B2.14 Talaromyces flavus, in particular strain V117b; B2.15 Trichoderma asperellum, in particular the strains ICC 012 or SKT-1 from Isagro (e.g. ECO-HOPE® from Kumiai Chemical Industry), T34 (e.g. ASPERELLO® from Biobest Group NV and T34 BIOCONTROL® by Biocontrol Technologies SL, ES); B2.16 Trichoderma atroviride, in particular the strain CNCM I-1237 (e.g. Esquive® WP from Agrauxine, FR), SC1 (described in International Application No. PCT / IT2008 / 000196), 77B (Andermatt Biocontrol T77 from Trichoderma harmatum), strain number V08 / 002387, strain NMI number V08 / 002388, strain NMI number V08 / 002389, strain NMI number V08 / 002390, strain LC52 (e.g. Sentinel from Agrimm Technologies Limited), strain LUI32 (e.g. Tenet from Agrimm Technologies Limited), strain ATCC 20476 (IMI 206040), strain T11 (IMI352941 / CECT20498), strain SKT-1 (FERM P-16510), strain SKT-2 (FERM P-16511), strain SKT-3 (FERM P-17021);B2.17 Trichoderma harmatum;B2.18 Trichoderma harzianum, in particular strains KD, T-22 (e.g. Trianum-P from Koppert), TH35 (e.g. Root-Pro by Mycontrol), DB 103 (e.g. T-Gro 7456 by Dagutat Biolab); B2.19 Trichoderma virens (also known as Gliocladium virens), in particular strain GL-21 (e.g. SoilGard by Certis, US); B2.20 Trichoderma viride, in particular strain TV1 (e.g. Trianum-P by Koppert), B35 (Pietr et al., 1993, Zesz. Nauk.AR w Szczecinie 161:125-137; B2.21 Ampelomyces quisqualis, in particular the strain AQ 10 (e.g. AQ 10® by CBC Europe, Italy); B2.22 Arkansas fungus 18, ARF; B2.23 Aureobasidium pullulans, in particular blastospores of the strain DSM 14940, blastospores of the strain DSM 14941 or a mixture of blastospores of the strains DSM 14940 and DSM 14941 (e.g. Botector® by bio-ferm, CH); B2.24 Chaetomium cupreum (e.g. BIOKUPRUM TM by AgriLife); B2.25 Chaetomium globosum (e.g. Rivadiom by Rivale); B2.26 Cladosporium cladosporioides, in particular the strain H39 (Stichting Dienst Landbouwkundig Onderzoek;B2.27 Dactylaria candida;B2.28 Dilophosphora alopecuri (e.g. Twist Fungus);B2.29 Fusarium oxysporum, in particular strain Fo47 (e.g. Fusaclean by Natural Plant Protection);B2.30 Gliocladium catenulatum (synonym: Clonostachys rosea f. catenulate), in particular strain J1446 (e.g. Prestop® by Lallemand);B2.31 Lecanicillium lecanii (formerly known as Verticillium lecanii), in particular conidia of strain KV01 (e.g. Vertalec® by Koppert / Arysta);B2.32 Penicillium vermiculatum;;B2.33 Trichoderma gamsii (formerly T. viride), especially strain ICC080 (IMI CC 392151 CABI, e.g. BioDerma by AGROBIOSOL DE MEXICO, SADE CV);B2.34 Trichoderma polysporum, in particular strain IMI 206039 (e.g. Binab TF WP by BINAB Bio-Innovation AB, Sweden); B2.35 Trichoderma stromaticum (e.g. Tricovab by Ceplac, Brazil); B2.36 Tsukamurella paurometabola, in particular strain C-924 (e.g. HeberNem®); B2.37 Ulocladium oudemansii, in particular strain HRU3 (e.g. Botry-Zen® by Botry-Zen Ltd, NZ); B2.38 Verticillium albo-atrum (formerly V. dahliae), in particular strain WCS850 (CBS 276.92; e.g. Dutch Trig by Tree Care Innovations); B2.39 Muscodor roseus, in particular strain A3-5 (Accession No. NRRL 30548); B2.40 Verticillium chlamydosporium; B2.41 a mixture of Trichoderma asperellum strain ICC 012 and Trichoderma gamsii strain ICC 080 (e.g. the product known as BIO-TAM® from Bayer CropScience LP, US), B2.42 Simplicillium lanosoniveum and B2.43 Trichoderma fertile (e.g. the product TrichoPlus from BASF).

[0068] In a preferred embodiment, the biocide with fungicidal activity is Coniothyrium minitans, in particular strain CON / M / 91-8 (accession number DSM-9660); Aspergillus flavus, strain NRRL21882 (available from Syngenta as Afla-Guard®) and strain AF36 (available from the Arizona Cotton Research and Protection Council, US); Gliocladium roseum strains 321U, ACM941, IK726, 88-710 (WO2007 / 107000), CR7 (WO2015 / 035504); Gliocladium catenulatum strain J1446; Phlebiopsis (or Phlebia or Peniophora) gigantea, in particular strain VRA 1835 (ATCC 90304), VRA 1984 (DSM 16201), VRA 1985 strain (DSM16202), VRA 1986 strain (DSM16203), FOC PG B20 / 5 strain (IMI390096), FOC PG SP log 6 strain (IMI390097), FOC PG SP log5 strain (IMI390098), FOC PG BU3 strain (IMI390099), FOC PG BU4 strain (IMI390100), FOC PG 410.3 strain (IMI39010101), FOC PG 97 / 1062 / 116 / 1.1 strain (IMI390102), FOC PG B22 / SP1287 / 3.1 strain (IMI390103), FOC PG SH1 strain (IMI390104), FOC PG B22 / SP1190 / 3.2 strain (IMI390105) (available as Rotstop® from Verdera and FIN, and as PG-Agromaster®, PG-Fungler®, PG-IBL®, PG-Poszwald® and Rotex® from e-nema, DE); Pythium oligandrum, strain DV74 or M1 (ATCC 38472) (available as Polyversum from Bioprepraty, CZ); Talaromyces flavus, strain VII7B; Ampelomyces quisqualis, in particular strain AQ 10 (available as AQ 10® from CBC Europe, Italy); Gliocladium catenulatum (syn: Clonostachys rosea f. catenulate) strain J1446, Cladosporium cladosporioides, e.g. strain H39 (Stichting Dienst from Landbouwkundig Onderzoek), Trichoderma virens (also known as Gliocladium virens), in particular strain GL-21 (e.g. Certis, SoilGard by US), Trichoderma atroviride strains CNCM I-1237, 77B, LU132 or SC1 (having the accession number CBS 122089), Trichoderma harzianum strain T-22 (e.g. Trianum-P from Andermatt Biocontrol or Koppert), Trichoderma asperellum strain SKT-1 (having the accession number FERM P-16510) or strain T34, Trichoderma viride strain B35 and Trichoderma asperelloides JM41R (having the accession number NRRL B-50759).

[0069] In a more preferred embodiment, the fungal species having fungicidal activity is selected from Coniothyrium minitans, in particular strain CON / M / 91-8 (accession number DSM-9660) (available under the trademark Contans® from Prophyta, DE); Gliocladium roseum strain 321U, strain ACM941 or strain IK726; Gliocladium catenulatum strain J1446; Trichoderma virens (also known as Gliocladium virens) strain GL-21. The fungal species may also preferably be Coniothyrium minitans strain CON / M / 91-8 (accession number DSM-9660) or Gliocladium catenulatum strain J1446 or Trichoderma atroviride strain CNCM I-1237 or Trichoderma viride strain B35.

[0070] Among fungicidal fungi, the genus Trichoderma, especially Trichoderma viride and Trichoderma atroviride species, are particularly preferred.These include Trichoderma atroviride strain CNCM I-1237; Trichoderma atroviride strain SC1 (with accession number CBS 122089), WO 2009 / 116106 and US Patent No. 8,431,120 (from Bi-PA); Trichoderma atroviride strain 77B; Trichoderma atroviride strain LU132; Trichoderma viride strain B35.Particularly preferred are Trichoderma atroviride strain CNCM I-1237 and Trichoderma viride strain B35.

[0071] The fungal species may be an entomopathogenic fungus.

[0072] Fungi active against insects (entomopathogenic fungi) include: C2.1 Muscodor albus, in particular strain QST 20799 (accession number NRRL 30547); C2.2 Muscodor roseus, in particular strain A3-5 (accession number NRRL 30548); C2.3 Beauveria bassiana, in particular strain ATCC 74040 (e.g. Naturalis® from Intrachem Bio Italia); strain GHA (accession number ATCC 74250; e.g. BotaniGuard Es and Mycotrol-O from Laverlam International Corporation); strain ATP02 (accession number DSM 24665); strain PPRI 5339 (e.g. BroadBand® from BASF); strain PPRI 7315, strain R444 (e.g. Andermatt Bb-Protec from Biocontrol), strains IL197, IL12, IL236, IL10, IL131, IL116 (see Jaronski, 2007. Use of Entomopathogenic Fungi in Biological Pest Management, 2007: ISBN: 978-81-308-0192-6), strain Bv025 (see, for example, Garcia et al., Manejo Integrado de Plagas y Agroecologia (Costa Rica) No. 77); strain BaGPK; strain ICPE 279, strain CG 716 (Novozymes C2.4 Hirsutella citriformis; C2.5 Hirsutella thompsonii (e.g. Mycohit and ABTEC from Agro Bio-tech Research Centre, IN); C2.6 Lecanicillium lecanii strains (formerly known as Verticillium lecanii), in particular conidia of the strain KV01 (Mycotal® and Vertalec® from Koppert / Arysta), strains DAOM198499 or strains DAOM216596; C2.9 Lecanicillium muscarium strains (formerly Verticillium lecanii), in particular strains VE 6 / CABI(=IMI)268317 / CBS102071 / ARSEF5128 (e.g. Mycotal from Koppert); C2.10 Metarhizium anisopliae var acridum, for example GreenGuard by Becker Strain ARSEF324 or isolate IMI 330189 from Underwood, US (ARSEF7486; e.g. Green Muscle by Biological Control Products); C2.11 Metarhizium brunneum, e.g. strain Cb 15 (e.g. ATTRACAP® from BIOCARE); C2.12 Metarhizium anisopliae, e.g. strain ESALQ 1037 (e.g. from Metalril® SP Organic), strain E-9 (e.g. from Metalril® SP Organic), strain M206077, strain C4-B (NRRL 30905), strain ESC1, strain 15013-1 (NRRL 67073), strain 3213-1 (NRRL 67074), strain C20091, strain C20092, strain F52 (DSM3884 / ATCC 90448; e.g., Bio 1020 by Bayer CropScience and Met52 by Novozymes) or ICIPE 78; C2.15 Metarhizium robertsii 23013-3 (NRRL 67075); C2.13 Nomuraea rileyi; C2.14 Paecilomyces fumosoroseus (new: Isaria fumosorosea), especially strain Apopka 97 (available as PreFeRal from Certis, USA), Fe9901 (available as NoFly from Natural industries, USA), ARSEF 3581, ARSEF 3302, ARSEF 2679 (ARS Collection of Entomopathogenic Fungal Cultures, Ithaca, USA), IfB01 (China Center for Type Culture Collection CCTCC M2012400), ESALQ1296, ESALQ1364, ESALQ1409 (ESALQ: University of Sao Paulo (Piracicaba, SP, Brazil)), CG1228 (EMBRAPA Genetic Resources and Biotechnology (Brasilia, DF, Brazil)), KCH J2 (Dymarska et al., 2017; PLoS one 12(10):e0184885), HIB-19, HIB-23, HIB-29, HIB-30 (Gandarilla-Pacheco et al., 2018; Rev Argent Microbiol 50:81-89), CHE-CNRCB 304, EH-511 / 3 (Flores-Villegas et al., 2016; Parasites & Vectors 2016 9:176 doi:10.1186 / s13071-016-1453-1), CHE-CNRCB 303, CHE-CNRCB 305, CHE-CNRCB 307 (Gallou et al., 2016; fungal biology 120(2016)414-423), EH-506 / 3, EH-503 / 3, EH-520 / 3, PFCAM, MBP, PSMB1 (National Center for Biololgical Control, Mexico; Castellanos-Moguel et al., 2013; Revista Mexicana De Micologia 38:23-33, 2013), RCEF3304 (Meng et al., 2015; Genet Mol Biol.2015 Jul-Sep; 38(3):381-389), PF01-N10 (CCTCC No. M207088), CCM 8367 (Czech Collection of Microorganisms, Brno), SFP-198 (Kim et al., 2010; Wiley Online: DOI 10.1002 / ps.2020), K3 (Yanagawa et al., 2015; J Chem Ecol. 2015; 41(12): 118-1126), CLO 55 (Ansari Ali et al., 2011; PLoS One. 2011; 6(1):e16108. DOI: 10.1371 / journal.pone.0016108), IfTS01, IfTS02, IfTS07 (Dong et al., 2016 / PLoS ONE 11(5):e0156087.doi:10.1371 / journal.pone.0156087), P1 (Sun Agro Biotech Research Centre, India), If-02, If-2.3, If-03 (Farooq and Freed, 2016; DOI: 10.1016 / j.bjm.2016.06.002), Ifr AsC (Meyer et al., 2008; J. Invertebr. Pathol. 99:96-102.10.1016 / j.jip.2008.03.007), PC-013 (DSMZ 26931), P43A, PCC (Carrillo-Perez et al., 2012; DOI 10.1007 / s11274-012-1184-1), Pf04, Pf59, Pf109 (Kim Jun et al., 2013; Mycobiology 2013 Dec;41(4):221-224), FG340 (Han et al., 2014; DOI: 10.5941 / MYCO.2014.42.4.385), Pfr1, Pfr8, Pfr9, Pfr10, Pfr11, Pfr12 (Angel-Sahagun et al., 2005; Journal of Insect Science), Ifr531 (Daniel and Wyss, 2009; DOI 10.1111 / j.1439-0418.2009.01410.x), IF-1106 (Insect Ecology and Biocontrol Laboratory, Shanxi Agricultural University), I9602, I7284 (Hussain et al., 2016, DOI: 10.3390 / ijms17091518), I03011 (Patent US 4618578), CNRCB1 (Centro Nacional de Referencia de Control Biologico (CNRCB), Colima, Mexico), SCAU-IFCF01 (Nian et al., 2015; DOI: 10.1002 / ps.3977), PF01-N4 (Engineering Research Center of Biological Control, SCAU, Guangzhou, P.R. China), Pfr-612 (Institute of Biotechnology (IB-FCB-UANL), Mexico), Pf-Tim, Pf-Tiz, Pf-Hal, Pf-Tic (Chan-Cupul et al., 2013, DOI: 10.5897 / AJMR12.493); C2.15 Aschersonia aleyrodis; C2.16 Beauveria brongniartii (e.g., Beaupro from Andermatt Biocontrol AG); C2.17 Conidiobolus obscurus; C2.18 Entomophthora virulenta (e.g., Vektor from Ecomic); C2.19 Lagenidium giganteum; C2.20 Metarhizium flavoviride; C2.21 Mucor haemelis (e.g., BioAvard from Indore Biotech Inputs & Research); C2.22 Pandora delphacis; C2.23 Sporothrix insectorum (e.g., Sporothrix Es from Biocerto, BR); C2.24 Zoophtora radicans.

[0073] In a preferred embodiment, the fungal strains having insecticidal effect are C2.3 Beauveria bassiana strain ATCC 74040; strain GHA (accession number ATCC 74250); strain ATP02 (accession number DSM 24665); strain PPRI 5339; strains PPRI 7315, R444, IL197, IL12, IL236, IL10, IL131, IL116; strain BaGPK; strain ICPE 279, strain CG 716; C2.6 Lecanicillium lecanii (formerly known as Verticillium lecanii), in particular conidia of strain KV01, strain DAOM198499 or strain DAOM216596; C2.9 Lecanicillium muscarium (formerly Verticillium lecanii) strain VE 6 / CABI (=IMI) 268317 / CBS102071 / ARSEF5128; C2.10 Metarhizium anisopliae var acridum ARSEF324 or isolate IMI 330189 (ARSEF7486); C2.11 Metarhizium brunneum Cb 15; C2.12 Metarhizium anisopliae, e.g. ESALQ 1037, E-9, M206077, C4-B (NRRL 30905), ESC1, 15013-1 (NRRL 67073), 3213-1 (NRRL 67074), C20091, C20092, F52 (DSM3884 / ATCC 90448) or ICIPE 78; C2.14 Paecilomyces fumosoroseus (new: Isaria fumosorosea) Apopka 97, Fe9901, ARSEF 3581, ARSEF 3302, ARSEF 2679, IfB01 (China Center for Type Culture Collection CCTCC M2012400), ESALQ1296, ESALQ1364, ESALQ1409, CG1228, KCH J2, HIB-19, HIB-23, HIB-29, HIB-30, CHE-CNRCB 304, EH-511 / 3, CHE-CNRCB 303, CHE-CNRCB 305, CHE-CNRCB 307, EH-506 / 3, EH-503 / 3, EH-520 / 3, PFCAM, MBP, PSMB1, RCEF3304, PF01-N10 (CCTCC No. M207088), CCM 8367, SFP-198, K3, CLO 55, IfTS01, IfTS02, IfTS07, P1, If-02, If-2.3, If-03, Ifr AsC, and PC-013 (DSMZ 26931), P43A, PCC, Pf04, Pf59, Pf109, FG340, Pfr1, Pfr8, Pfr9, Pfr10, Pfr11, Pfr12, Ifr531, IF-1106, I9602, I7284, I03011 (Patent US 4618578), CNRCB1, SCAU-IFCF01, PF01-N4, Pfr-612, Pf-Tim, Pf-Tiz, Pf-Hal and Pf-Tic.; and C2.16 Beauveria brongniartii (e.g. Beaupro from Andermatt Biocontrol AG).

[0074] In a more preferred embodiment, the fungal strains having insecticidal activity are C2.3 Beauveria bassiana strain ATCC 74040; strain GHA (accession number ATCC 74250); strain ATP02 (accession number DSM 24665); strain PPRI 5339; strain PPRI 7315 and / or strain R444; C2.6 Lecanicillium lecanii (formerly known as Verticillium lecanii), conidia of strains KV01, DAOM198499 or DAOM216596; C2.9 Lecanicillium muscarium (formerly Verticillium lecanii), in particular strain VE 6 / CABI (= IMI) 268317 / CBS102071 / ARSEF5128; C2.10 Metarhizium anisopliae var acridumARSEF324 or isolate IMI 330189 (ARSEF7486); C2.11 Metarhizium brunneum strain Cb 15; C2.12 Metarhizium anisopliae strains ESALQ 1037, E-9, M206077, C4-B (NRL 30905), ESC1, 15013-1 (NRL 67073), 3213-1 (NRL 67074), C20091, C20092, F52 (DSM3884 / ATCC 90448) or ICIPE 78; C2.14 Paecilomyces fumosoroseus (novel: Isaria fumosorosea) strains Apopka 97 and Fe9901, and C2.16 Beauveria brongniartii (e.g., Andermatt (Beaupro from Biocontrol AG).

[0075] More preferably, said fungal microorganism is a strain of the species Isaria fumosorosea.

[0076] Preferred strains of Isaria fumosorosea are Apopka 97, Fe9901, ARSEF 3581, ARSEF 3302, ARSEF 2679, IfB01 (China Center for Type Culture Collection CCTCC M2012400), ESALQ1296, ESALQ1364, ESALQ1409, CG1228, KCH J2, HIB-19, HIB-23, HIB-29, HIB-30, CHE-CNRCB 304, EH-511 / 3, CHE-CNRCB 303, CHE-CNRCB 305, CHE-CNRCB 307, EH-506 / 3, EH-503 / 3, EH-520 / 3, PFCAM, MBP, PSMB1, RCEF3304, PF01-N10 (CCTCC No. M207088), CCM 8367, SFP-198, K3, CLO 55, IfTS01, IfTS02, IfTS07, P1, If-02, If-2.3, If-03, Ifr AsC, PC-013 (DSMZ 26931), P43A, PCC, Pf04, Pf59, Pf109, FG340, Pfr1, Pfr8, Pfr9, Pfr10, Pfr11, Pfr12, Ifr531, IF-1106, I9602, I7284, I03011 (US Patent 4618578), CNRCB1, SCAU-IFCF01, PF01-N4, Pfr-612, Pf-Tim, Pf-Tiz, Pf-Hal, Pf-Tic.

[0077] Most preferably, said Isaria fumosorosea strain is selected from Apopka 97 and Fe9901. A particularly preferred strain is APOPKA97.

[0078] Also particularly preferred are the entomopathogenic fungi of the genus Metarhizium. The genus Metarhizium is composed of several species that have been recently reclassified (see Bischoff et al., 2009; Mycologia 101(4):512-530 for an overview). The members of the genus Metarhizium are M.pingshaense, M.anisopliae, M.robertsii, M.brunneum (these four are also called the Metarhizium anisopliae complex), M.acridum, M.majus, M.guizouense, M.Lepidiotae, M.Globosum and M.rileyi (previously known as Nomuraea rileyi). Of these, M.anisopliae, M.robertsii, M.brunneum, M.acridum and M.rileyi are more preferred, while those of M.brunneum are most preferred.

[0079] Particularly preferred exemplary strains belonging to Metarhizium are Metarhizium acridum ARSEF324 (product GreenGuard by BASF) or isolate IMI 330189 (ARSEF7486; e.g. Green Muscle by Biological Control Products); Metarhizium brunneum strain Cb 15 (e.g. ATTRACAP® from BIOCARE), or strain F52 (DSM3884 / ATCC90448; e.g. BIO 1020 by Bayer CropScience and Met52 by Novozymes); Metarhizium anisopliae complex strain ESALQ 1037 or ESALQ E-9 (both from Metalril® WP Organic), strain M206077, strain C4-B (NRRL 30905), strain ESC1, strain 15013-1 (NRRL 67073), 3213-1 (NRRL 67074), C20091, C20092, or ICIPE 78. Most preferred are isolates F52 (also known as Met52), which primarily infect beetle larvae and were originally developed for the control of Otiorhynchus sulcatus, and ARSEF324, which is used commercially for locust control. Commercially available products based on the F52 isolate are subcultures of the individual isolate F52 and are included in the following culture collections: Julius Kuhn-Institute for Biological Control (formerly BBA), Darmstadt, Germany: [as Ma43]; HRI, UK: [275-86 (acronym V275 or KVL 275)]; KVL Denmark [KVL 99-112 (Ma 275 or V 275)]; Bayer, Germany [DSM 3884]; ATCC, USA [ATCC 90448]; USDA, Ithaca, USA [ARSEF 1095].Granules and emulsifiable concentrate formulations based on this isolate have been developed by several companies for use against orange-spotted weevils and other beetles (Coleoptera) on ornamental plants and soft fruit in nurseries, western flower thrips on ornamental plants in greenhouses, and American long-horned stink bugs in turfgrasses. Registered in the U.S. and North America (U.S. and Canada).

[0080] Beauveria bassiana is mass-produced and used to control a wide variety of insect pests, including whiteflies, thrips, aphids, and weevils.Preferred strains of Beauveria bassiana include ATCC 74040; GHA (Accession No. ATCC74250); ATP02 (Accession No. DSM 24665); PPRI 5339; PPRI 7315, IL197, IL12, IL236, IL10, IL131, IL116, Bv025; BaGPK; ICPE 279, CG 716; ESALQPL63, ESALQ447, and ESALQ1432, CG1229, IMI389521, NPP111B005, and Bb-147. Most preferably, the Beauveria bassiana strains include strains ATCC 74040 and GHA (Accession No. ATCC 74250).The liquid formulation according to any one of claims 1 to 17, wherein the fungal species is a nematicidally active fungus.

[0081] Nematicidally active fungal species include: D2.1 Muscodor albus, in particular strain QST 20799 (accession number NRRL 30547); D2.2 Muscodor roseus, in particular strain A3-5 (accession number NRRL 30548); D2.3 Purpureocillium lilacinum (formerly known as Paecilomyces lilacinus), in particular strain P. lilacinum 251 (AGAL 89 / 030550; e.g. BioAct from Bayer CropScience Biologics GmbH), strain 580 (BIOSAT® WP by Laverlam (ATCC number 38740)), strains in the product BIO-NEMATON® (T. Stanes and Company Ltd.), strains in the product MYSIS® (Varsha Bioscience and Technology India Pvt Lt.), strains in the product BIOICONEMA® (Nico Orgo D2.4 Trichoderma koningii; D2.5 Harposporium anguillullae; D2.6 Hirsutella minnesotensis; D2.7 Monacrosporium cionopagum; D2.8 Monacrosporium psychrophilum; D2.9 Myrothecium verrucaria, in particular strain AARC-0255 (e.g. DiTera™ from Valent Biosciences); D2.10 Paecilomyces variotii, strain Q-09 (Nemaquim™ from Quimia, MX); D2.11 Stagonospora phaseoli (e.g. from Syngenta); D2.12 Trichoderma lignorum, especially strain TL-0601 (e.g., Mycotric from Futureco Bioscience, ES); D2.13 Fusarium solani, strain Fs5; D2.14 Hirsutella solani; D2.15 Monacrosporium drechsleri; D2.16 Monacrosporium gephyropagum; D2.17 Nematoctonus geogenius; D2.18 Nematoctonus leiosporus; D2.19 Neocosmospora vasinfecta; D2.20 Paraglomus sp, especially Paraglomus brasilianum; D2.21 Pochonia chlamydosporia (also known as Vercillium chlamydosporium), especially var. catenulata (IMI SD 187; e.g., KlamiC from The National Center of Animal and Plant Health (CENSA), CU); D2.22 Stagonospora heteroderae; D2.23 Meristacrum asterospermum and D2.24 Duddingtonia flagrans.

[0082] In a more preferred embodiment, the fungal strain having nematicidal effect is selected from Purpureocillium lilacinum, in particular strain Plilacinum 251 (AGAL 89 / 030550); Harposporium anguillullae; Hirsutella minnesotensis; Monacrosporium cionopagum; Monacrosporium psychrophilum; Myrothecium verrucaria, strain AARC-0255; Paecilomyces variotii; Stagonospora phaseoli (commercially available from Syngenta); and spores of Duddingtonia flagrans.

[0083] In an even more preferred embodiment, the fungal strain with nematicidal effect is selected from Purpureocillium lilacinum, in particular strain P. lilacinum 251 (AGAL 89 / 030550); and Duddingtonia flagrans spores. Most preferably, said fungal strain with nematicidal effect is from the species Purpureocillium lilacinum, in particular strain P. lilacinum 251.

[0084] The fungal microorganisms which produce spores and act as biological control agents and / or plant growth promoters are cultured or fermented on a suitable substrate according to methods known in the art or as described herein, e.g., by submerged or solid-state fermentation, using devices and methods such as those disclosed in WO2005 / 012478 or WO1999 / 057239.

[0085] While certain fungal propagules such as microsclerotia (see, e.g., Jackson and Jaronski (2009). Production of microsclerotia of the fungal entomopathogen Metarhizium anisopliae and their potential for use as a biocontrol agent for soil-inhabiting insects; Mycological Research 113, pp. 842-850) can be produced by liquid fermentation techniques, it is preferred that the dormant structures or organs according to the invention are produced by solid-state fermentation. Solid-state fermentation techniques are well known in the art (for an overview, see Gowthaman et al., 2001. Appl Mycol Biotechnol (1), p. 305-352).

[0086] After fermentation, the fungal spores can be separated from the substrate. The substrate on which the fungal spores are present is preferably dried before any separation step. After separation, the microorganism or fungal spores can be dried, for example, via freeze-drying, vacuum drying or spray drying. Methods for preparing dried spores are well known in the art and include fluidized bed drying, spray drying, vacuum drying and freeze-drying. Conidia can be dried in two stages: for conidia produced by solid-state fermentation, first, the culture substrate covered with conidia is dried, and then the conidia are harvested from the dried culture substrate, thereby obtaining pure conidia powder. The conidia powder is then further dried using vacuum drying or freeze-drying before storing or formulating it.

[0087] The liquid preparation according to the invention may further comprise at least one substance selected from the group of surfactants, rheology modifiers, antifoam agents, antioxidants and dyes.

[0088] Nonionic and / or anionic surfactants are all substances of this type that can be conventionally used in agrochemicals. Possible nonionic surfactants are selected from the group of polyethylene oxide-polypropylene oxide block copolymers, polyethylene glycol ethers of branched or linear alcohols, reaction products of fatty acids or fatty alcohols with ethylene oxide and / or propylene oxide, and also branched or linear alkyl ethoxylates and alkylaryl ethoxylates (here, polyethylene oxide-sorbitan fatty acid esters can be mentioned as examples). From among the above examples, selected classes can optionally be phosphoric acid-treated and neutralized with bases. Alkali metal, alkaline earth metal and ammonium salts of alkylsulfonic or alkylphosphoric acids and alkylarylsulfonic or alkylarylphosphoric acids are preferred. A further preferred group of anionic surfactants or dispersing aids are the alkali metal, alkaline earth metal and ammonium salts of polystyrenesulfonic acid, the salts of polyvinylsulfonic acid, the salts of alkylnaphthalenesulfonic acids, the salts of naphthalenesulfonic acid-formaldehyde condensation products, the salts of condensation products of naphthalenesulfonic acid, phenolsulfonic acid and formaldehyde, and the salts of lignosulfonic acid.

[0089] Rheology modifiers, also known as thickeners, anti-caking agents, viscosity modifiers or structurants, may be added to the formulations of the invention, for example to prevent (irreversible) settling. The rheology modifiers are preferably derived from minerals. These rheology control agents provide long-term stability when the formulation is at rest or in storage. Suitable compounds are rheology modifiers selected from the group consisting of hydrophilic and hydrophobized fumed and precipitated silica particles, gelling clays including bentonite, hectorite, laponite, attapulgite, sepiolite, smectite, or hydrophobic / organophilic modified bentonite. Suitable ranges of rheology modifiers in the liquid formulations according to the invention include 0-10%, preferably 0-7%, more preferably 0.5-5%.

[0090] Unless otherwise defined, % in this application means % by weight.

[0091] To disperse silica or clay thickeners in a given fluid, high shear mixing is desirable to form a gel, as is known in the art.

[0092] The major world producers of fumed (pyrogenic) hydrophilic or hydrophobized silica are Evonik (trade name Aerosil®), Cabot Corporation (trade name Cab-O-Sil®), Wacker Chemie (HDK product range), Dow Corning, and OCI (Konasil®). Another class of suitable rheology modifiers is precipitated silica, the major world producers being Evonik (trade name Sipernat® or Wessalon®), Rhodia (Tixosil) and PPG Industries (Hi-Sil).

[0093] Another suitable example of a class of rheology modifiers are clay thickeners. Clay thickeners are generally finely divided layered silicates that can be effective thickeners for a wide range of applications. They are typically used in either their non-hydrophobized or hydrophobized forms. To make them dispersible in non-aqueous solvents, the clay surface is usually treated with a quaternary ammonium salt. These modified clays are known as organically modified clay thickeners. Optionally, a small amount of low molecular weight alcohol or water can be used as an activator. Examples of such clay-based rheology modifiers include smectite, bentonite, hectorite, attapulgite, sepiolite or montmorillonite clays.

[0094] Preferred rheology modifiers (b) are, for example, organically modified hectorite clays, such as Bentone® 38 and SD3, organically modified bentonite clays, such as Bentone® 34, SD1 and SD2, organically modified sepiolites, such as Pangel® B20, hydrophilic silicas, such as Aerosil® 200, hydrophobized silicas, such as Aerosil® R972, R974 and R812S, attapulgites, such as Attagel® 50.

[0095] Another suitable example of a rheology modifier is an organic rheology modifier based on modified hydrogenated castor oil (trihydroxystearin) or organic derivatives of castor oil such as Thixcin® R and Thixatrol® ST.

[0096] Physical Properties of Selected Rheology Modifiers [Table 1] TIFF0007579776000004.tif154152

[0097] In a preferred embodiment, the concentration of the rheology modifier is in the range of 0-10% by weight, for example 1-7 or 3-6% by weight. In particular, the concentration of the rheology modifier may be 0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8 or 9% by weight, essentially depending on the physical properties of the biocontrol agent as well as the physical properties of the carrier liquid. In general, the concentration of the rheology modifier in the formulation according to the present invention may also depend on the biocontrol agent.

[0098] Antifoaming agents may be added to the formulation to prevent foaming upon dilution with water. Suitable antifoaming agents are, for example, paraffin oil, vegetable oil, silicone oil (e.g., Silcolapse 411, Silcolapse 454, Silcolapse 482 from Solvay; Silfoam SC1132, Silfoam SC132 from Wacker; Xiameter ACP-0100 from Dow), or aqueous silicone oil emulsions (e.g., SAG30, SAG1572 / Momentive, Silcolapse 426R, Silcolapse 432 / Solvay; Silfar SE4 / Wacker; Antifoam 8830 / Harcros Chemicals). In a preferred embodiment, the concentration of the antifoaming agent is in the range of 0-0.5% by weight, for example 0.1-0.3% by weight. In particular, the concentration of the antifoam agent may be 0, 0.1, 0.2, 0.3, 0.4 or 0.5 wt % or any value therebetween.

[0099] Antioxidants may be added to the formulation to prevent or slow down the oxidative degradation process.Suitable antioxidants are, for example, tert.-butylhydroxyquinone (TBHQ), butylhydroxytoluene (BHT), butylhydroxyanisole (BHA), ascorbyl palmitate, tocopheryl acetate, ascorbyl stearate or the group of carotenoids (e.g., β-carotene) or gallates (e.g., ethyl gallate, propyl gallate, octyl gallate, dodecyl gallate).

[0100] Dyes that can be used include inorganic pigments, such as iron oxide, titanium oxide, and Prussian blue, and organic dyes, such as alizarin dyes, azo dyes, and metal phthalocyanine dyes.

[0101] In a different aspect, the present invention relates to a liquid composition comprising a liquid preparation according to the present invention.

[0102] The present invention also relates to a method for controlling phytopathogenic fungi, insects and / or nematodes in or on a plant, for enhancing plant growth or for improving plant health, including plant yield or root growth, comprising applying to the plant or to the locus where the plant is growing or intended to grow an effective amount of a liquid preparation or liquid composition according to the invention as described above.

[0103] The term "plant health" generally includes various types of improvements in plants that are not related to the control of pests or plant pathogens. For example, advantageous characteristics that can be mentioned are improved crop characteristics, including: emergence, crop yield, protein content, oil content, starch content, more developed root system, improved root growth, improved root size maintenance, improved root effectiveness, improved stress tolerance (e.g., against drought, heat, salt, UV, water, cold), reduced ethylene (reduced production and / or inhibition of reception), increased tillering, increased plant height, larger leaf blades, smaller dead basal leaves, stronger tillers, greener leaf color, pigment content, photosynthetic activity, less required inputs (e.g., fertilizer or water), fewer seeds, more productive tillers, earlier flowering, earlier grain maturation, less plant wandering (lodging), increased shoot growth, enhanced plant vigor, increased plant stand, and earlier and better germination.

[0104] Improved plant health preferably refers to improved plant characteristics including: crop yield, more developed root system (improved root growth), improved root size maintenance, improved root effectiveness, increased tillering, increased plant height, larger leaf blades, fewer dead basal leaves, stronger tillers, greener leaf color, photosynthetic activity, more productive tillers, enhanced plant vigor, and increased plant stand.

[0105] In the context of the present invention, improved plant health particularly preferably refers to improved plant characteristics selected from crop yield, a more developed root system, improved root growth, improved root size maintenance, improved root effectiveness, increased tillering, and increased plant height.

[0106] The effect of the composition according to the present invention on plant health as defined herein can be determined by comparing plants grown under the same environmental conditions, whereby parts of the plant are treated with the liquid preparation according to the present invention and other parts of the plant are not treated with the liquid preparation according to the present invention. Instead, the other parts are not treated at all or are treated with a placebo (i.e., application without any active ingredient (i.e., without any biological control agent as described herein)).

[0107] The liquid preparation according to the present invention can be applied in any desired manner, such as in the form of seed coating, soil dipping, and / or directly in furrow, and / or in the form of foliar spray, and can be applied either before emergence, after emergence, or both.In other words, the liquid preparation can be applied to seeds, plants, or harvested fruits and vegetables, or to the soil in which plants are growing, or to the soil where growth is desired (where plants are growing).Usual application methods include, for example, dipping, spraying, atomizing, irrigation, evaporation, dusting, misting, scattering, foaming, painting, spreading, spraying, drenching, and drip irrigation.

[0108] All plants and plant parts can be treated according to the invention. Plants are understood here to mean all plants and plant parts, such as desirable and undesirable wild plants or crop plants, including naturally occurring crop plants.

[0109] Plants which may be treated according to the invention include the following major crop plants: corn, soybean, alfalfa, cotton, sunflower, Brassica oilseeds, such as Brassica napus (e.g. canola, rapeseed), Brassica rapa, B. juncea (e.g. (field) mustard) and Brassica carinata, Arecaceae sp. (e.g. oil palm, coconut), rice, wheat, sugar beet, sugar cane, oats, rye, barley, millet and sorghum, triticale, flax, nuts, grapes and vines, as well as various fruits and vegetables from various plant taxa, such as Rosaceae sp. (e.g. fruits, such as apples and pears, as well as stone fruits, such as apricots, cherries, almonds, plums, peaches, and berries, such as strawberries, raspberries, red and black currants and gooseberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp. (e.g. olive trees), Actinidaceae sp., Lauraceae sp. (e.g. avocado, cinnamon, camphor), Musaceae sp. (e.g. banana trees and plantations), Rubiaceae sp. (e.g. coffee), Theaceae sp. (e.g. tea), Sterculiceae sp., Rutaceae sp. (e.g. lemon, orange, mandarin, grapefruit); Solanaceae sp. (e.g. tomato, potato, pepper, chilli, eggplant, tobacco), Liliaceae sp., Compositae sp. (e.g. lettuce, artichoke, chicory root, endive or common chicory), Umbelliferae sp. (e.g. carrot, parsley, celery and celeriac), Cucurbitaceae sp. (e.g. including cucumber gherkin, pumpkin, watermelon, gourd and melon), Alliaceae sp. (e.g. leeks and onions), Cruciferae sp.(e.g. white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, bok choy, khole rabi, radish, horseradish, watercress, Chinese cabbage), Leguminosae sp. (e.g. peanuts, peas, lentils and legumes such as beans and broad beans), Chenopodiaceae sp. (e.g. Swiss chard, fodder beet, spinach, beetroot), Linaceae sp. (e.g. hemp), Cannabeacea sp. (e.g. thyme), Malvaceae sp. (e.g. okra, cocoa), Papaveraceae (e.g. poppy), Asparagaceae (e.g. asparagus); useful and ornamental plants in the garden and woodland, including turf, lawn, grass and Stevia rebaudiana, and in each case genetically modified versions of these plants.

[0110] Crop plants may be plants that can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or a combination of these methods, including transgenic plants, and plant varieties that may or may not be protected by variety property rights. Plants should be understood to mean all developmental stages from seeds, seedlings, young (immature) plants to mature plants. Plant parts should be understood to mean all parts and organs of plants above and below ground, such as shoots, leaves, flowers and roots, examples of which include leaves, needles, stalks, stems, flowers, fruiting bodies, fruits and seeds, as well as tubers, roots and rhizomes. Plant parts also include harvested plants or harvested plant parts, as well as vegetative and reproductive propagation material (e.g. seedlings, tubers, rhizomes, cuttings and seeds).

[0111] The treatment according to the invention of plants and plant parts with said liquid preparations or with compositions comprising said liquid preparations is carried out by the usual treatment methods, for example by immersion, spraying, evaporation, misting, scattering, painting, pouring, and in the case of propagation material, in particular seeds, by applying one or more coatings, by applying the compounds directly or to the surroundings, environment or storage space.

[0112] As already mentioned above, according to the invention, it is possible to treat all plants and their parts. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological propagation methods such as crossing or protoplast fusion, as well as parts thereof, are also treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering methods, if appropriate in combination with conventional methods (genetically modified organisms) and their parts, are treated. The term "part" or "plant part" has been explained above. The invention is particularly preferably used to treat plants of the respective commercially conventional or used cultivars. Plant cultivars should be understood to mean plants having new properties ("traits") and obtained by conventional propagation, mutagenesis or recombinant DNA techniques. They may be cultivars, varieties, biotypes or genotypes.

[0113] Transgenic plants or plant cultivars (obtained by genetic engineering) which are preferably treated according to the invention include all plants which have received, by genetic modification, genetic material that confers to these plants particularly advantageous and useful properties ("traits"). Examples of such properties are better plant growth, increased resistance to high or low temperatures, increased resistance to drought or water or soil salinity levels, improved flowering performance, easier harvesting, accelerated ripening, higher yields, higher quality and / or higher nutritional value of the harvested products, better shelf life and / or processability of the harvested products. Further and particularly highlighted examples of such properties are increased resistance of the plant to pests and microbial pests, for example against insects, arachnids, nematodes, mites, slugs, snails, for example against toxins formed in the plant, in particular against Bacillus thuringiensis (e.g., by genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and combinations thereof), and increased resistance of plants to phytopathogenic fungi, bacteria and / or viruses, for example, by systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins, and increased resistance of plants to certain herbicidally active compounds, for example, imidazolinones, sulfonylureas, glyphosate, phosphinothricin (e.g., "PAT") genes). Genes conferring the desired traits of interest may also be present in combination with one another in the transgenic plants. Transgenic plants which may be mentioned are important crop plants, such as cereals (wheat, rice, triticale, barley, rye, oats), maize, soybean, potato, sugar beet, sugarcane, tomato, pea and other types of vegetables, cotton, tobacco, oilseed and fruit plants (including the fruits apple, pear, citrus fruit and grapes), with particular emphasis on maize, soybean, wheat, rice, potato, cotton, sugarcane, tobacco and oilseed.Traits that are particularly emphasized are increased plant resistance to insects, arachnids, nematodes, amphioxus and snails.

[0114] Furthermore, the present invention relates to the use of a liquid preparation or a liquid composition according to the invention as a plant protection agent or for promoting plant vitality and / or plant health.

[0115] The following examples illustrate the invention in a non-limiting manner.

[0116] material and method Carrier Fluid List: [Table 2] TIFF0007579776000006.tif181168 EXAMPLES

[0117] Example I (P. lilacinum) 3 g of P. lilacinum strain 251 pure spore powder was transferred to the formulation container (IKA Type DT-20 mixing container with dispersing tool for Ultra Turrax) using a sterile spoon. 12 mL of fluid was added to each formulation container and dispersed for 1 min at 3000 rpm using Ultra Turrax tube drive control and changed direction after 30 s. 2.8 mL of this was transferred to 4 sample bottles (Wheaton serum vials, type I) and sealed with crimp neck caps (Macherey-Nagel N type 13) leaving little head space, after which all sample bottles were transferred to an incubator set at 30 °C and stored for the designated time.

[0118] At regular intervals, samples were retrieved from storage and analyzed for spore viability. The original samples were therefore homogenized thoroughly. An aliquot of 0.25 g or 250 μL of each sample was transferred to a 50 mL Falcon tube. The tube was filled to 25 g with a sterile aqueous solution containing 2% Tween 80 and homogenized by vortexing to achieve the first dilution step (1:100 dilution). This dilution was used to further dilute and spot on the agar.

[0119] For the evaluation of spore germination rate, prepare a 1:30000 dilution based on the 1:100 dilution achieved by multiplex automated dilution (pipetting robot, 96-well plate). Then take a 12 x 12 cm agar plate and spot 10 times 5 μL of each sample using an automated 12-channel pipette. Wait until the liquid is soaked in the agar, transfer the agar plate to an incubator and incubate at 25 °C for 17 h. Open the plate and place it under a microscope. Randomly select one area per spot and record the number of germinated and non-germinated spores within the designated area. At least 200 spores per sample should be evaluated. If necessary, count two or more areas per spot.

[0120] The spore viability results are shown in Table I. [Table 3]

[0121] Discussion: From the results shown in Table I, it becomes clear that not all fluids are suitable to provide good spore viability after storage. Spore viability immediately after preparation of the samples (day 1) is generally high, often 80% or more, and often even 90% or more. Certain fluids not falling within the scope of the present invention show a steep decline in spore viability even one day after sample preparation, and even steeper declines even after storage under the given conditions (Table I, entries 5, 6, 14, 20, 23). BreakThru S240 has been previously described as a superior fluid to host fungal spores. Under the given test conditions, BreakThru S240 (Table I, entry 33) provides spore viability of ∼77% after 2 months of storage and ∼7% after 7 months of storage. Among the examples according to the present invention, fluids are selected that show spore viability of about 53% or more after 2 or 3 months of storage, respectively. In many cases, spore viability of about 80% or more was detected (Table I, entries 1, 7, 10, 11, 13, 15, 16, 18, 21, 26, 29). For selected fluids, exceptional spore viability was found even after 7 months of storage at 30°C (Table I, entries 25, 27, 32).

[0122] Example II (Isaria fumosorosea) Method 1: 1.5 g of Isaria fumosorosea pure spore powder was transferred to the formulation container (IKA Type DT-20 mixing container with dispersing tool for Ultra Turrax) using a sterile spoon. 13.5 mL of fluid was added to each formulation container and dispersed for 1 min at 3000 rpm using Ultra Turrax tube drive control, changing direction after 30 s. 2.8 mL of this was transferred to 4 sample bottles (Wheaton serum vials, type I) leaving little headspace and sealing with crimp neck caps (Macherey-Nagel N type 13), after which all sample bottles were transferred to an incubator set at 30 °C and stored for the indicated time.

[0123] At regular intervals, samples were retrieved from storage and analyzed for spore viability. The original samples were therefore homogenized thoroughly. An aliquot of 0.25 g or 250 μL of each sample was transferred to a 50 mL Falcon tube. The tube was filled to 25 g with a sterile aqueous solution containing 2% Tween 80 and homogenized by vortexing to achieve the first dilution step (1:100 dilution). This dilution was used to further dilute and spot on the agar.

[0124] For the evaluation of spore germination rates, a 1:15000 dilution based on a 1:100 dilution achieved by multiplex automated dilution (pipetting robot, 96-well plate) was prepared. A 12 x 12 cm agar plate was then taken and spotted with 10 replicates of 5 μL of each sample using an automated 12-channel pipette. After all the liquid was soaked into the agar, the agar plate was incubated at 23 °C for 16 h.

[0125] Method 2: 0.5 g of Isaria fumosoresea pure spore powder was transferred to an Erlenmeyer flask using a sterile spoon. 24.5 mL of fluid was dispersed with an Ultra-Turrax (IKA; Type T 25 D) for 1 min at 3,000 rpm. After this, 2.0 mL was transferred to 20 sample bottles (Wheaton serum vials, Type I) and sealed with crimp neck caps (Macherey-Nagel Type N 13) leaving little headspace. All sample bottles were then transferred to an incubator set at 30 °C and stored for the designated time.

[0126] At regular intervals, samples were retrieved from the storage site and analyzed for spore viability. For this purpose, the original samples were thoroughly homogenized. An aliquot of 0.5 g of each sample was transferred to a 100 mL Erlenmeyer flask. The flask was filled to 50 g with a sterile aqueous solution containing 0.1% Break Thru® S240 (Evonik, Industries) and homogenized for at least 15 minutes at 750 rpm on a magnetic stirrer (Thermo Fisher Scientific: Cimarec™) to achieve a first dilution step (1:100 dilution). This dilution was used for further dilutions.

[0127] Not all samples were mixed well or at all in the 0.1% Break Thru S240. For these samples, 500 μL of Neo-wett (Kwizda Agro GmbH) and / or a small amount (knife tip) of Metaupon®-OMT (LEUNA Tenside GmbH) was also added to the aqueous solution.

[0128] After homogenization, 1 mL was transferred to a 1.5 mL tube and centrifuged at 14,000 rpm for 15 min (Thermo Fisher Scientific, Type Megafuge 8R). The supernatant (=upper phase) was discarded using a pipette. The tube was filled to 1 mL using a sterile aqueous solution containing 0.1% Neo-wett and homogenized by vortexing.

[0129] A flow cytometry-based method was used to assess fungal viability.

[0130] The spore viability results are shown in Table II. [Table 4]

[0131] Discussion: The spore viability immediately after preparation of the samples (day 1) is generally high, often more than 90%, except for Butylcarbitol and Carbitol (Table II, entries 1, 2), which were used as negative standards (i.e. not according to the invention). As demonstrated in some examples (Table 2, entries 6 / 6a, 7 / 7a, 13 / 13a, 14 / 14a, 16 / 16a), both methods for the determination of spore viability provide comparable results. Among the examples according to the invention, fluids are selected that show a spore viability of about 60% or more after 1 month of storage (Table II, entries 3-7, 9-12, 14, 16, -1-20) or about 50% or more after 7 months of storage at 30° C. (Table 2, entries 6, 7, 14, 16, 19, 20).

[0132] Example III (Beauveria Bassiana) 1.5 g of Beauveria Bassiana pure spore powder was transferred to the formulation container (IKA Type DT-20 mixing container with dispersing tool for Ultra Turrax) using a sterile spoon. 13.5 mL of fluid was added to each formulation container and dispersed for 1 min at 3000 rpm using Ultra Turrax tube drive control, changing direction after 30 s. 2.8 mL of this was transferred to 4 sample bottles (Wheaton serum vials, type I) and sealed with crimp neck caps (Macherey-Nagel N type 13) leaving little head space, after which all sample bottles were transferred to an incubator set at 30 °C and stored for the designated time.

[0133] At regular intervals, samples were retrieved from storage and analyzed for spore viability. The original samples were therefore homogenized thoroughly. An aliquot of 0.25 g or 250 μL of each sample was transferred to a 50 mL Falcon tube. The tube was filled to 25 g with a sterile aqueous solution containing 2% Tween 80 and homogenized by vortexing to achieve the first dilution step (1:100 dilution). This dilution was used to further dilute and spot on the agar.

[0134] For the evaluation of spore germination rate, prepare a 1:15000 dilution based on the 1:100 dilution achieved by multiplex automated dilution (pipetting robot, 96-well plate). Then, take a 12 x 12 cm agar plate and spot each sample 10 times with 5 μL using an automated 12-channel pipette. Wait until the liquid is soaked into the agar, transfer the agar plate to an incubator and incubate at 20 °C for 17 h. Open the plate and place it under a microscope. Randomly select one area per spot and record the number of germinated and non-germinated spores within the designated area. At least 200 spores per sample should be evaluated. Count multiple areas per spot if necessary. The results of spore viability are shown in Table III. [Table 5]

[0135] Discussion: The spore viability immediately after preparation of the samples (day 1) is generally high, often 80% or more, and often even 90% or more. Fluids not falling within the scope of the present invention show a steep decline in spore viability after storage under the given conditions (Table III, entries 4, 12). Among the examples according to the present invention, fluids have been selected that show spore viability of about 50% or more after storage at 30° C. for 3 weeks or more (Table III, entries 1, 2, 3, 5, 9, 10, 14, 17). Example IV: Penicillium Bilaii 1.5 g of Penicillium bilaii (ATCC 20851) pure spore powder was transferred to the formulation vessel (IKA Type DT-20 mixing vessel with dispersing tool for Ultra Turrax) using a sterile spoon. 13.5 mL of fluid was added to the formulation vessel and dispersed for 1 min at 3000 rpm using Ultra Turrax tube drive control, changing direction after 30 s. After this, 2.8 mL was transferred to 4 sample bottles (Wheaton serum vials, type I) leaving almost no head space and sealing with crimp neck caps (Macherey-Nagel type N 13), after which all sample bottles were transferred to an incubator set at 30 °C and stored for the indicated time.

[0136] At regular intervals, samples were retrieved from storage and analyzed for spore viability. The original samples were therefore homogenized thoroughly. An aliquot of 0.25 g or 250 μL of each sample was transferred to a 50 mL Falcon tube. The tube was filled to 25 g with a sterile aqueous solution containing 2% Tween 80 and homogenized by vortexing to achieve the first dilution step (1:100 dilution). This dilution was further diluted and used to spot on the agar.

[0137] For the evaluation of spore germination rate, prepare a 1:15000 dilution based on the 1:100 dilution achieved by multiplex automated dilution (pipetting robot, 96-well plate). Then, take a 12 x 12 cm agar plate and spot 10 times with 5 μL of each sample using an automated 12-channel pipette. Wait until the liquid is soaked into the agar, transfer the agar plate to an incubator and incubate at 20 °C for 17 h. Open the plate and place it under a microscope. Randomly select one area per spot and record the number of germinated and non-germinated spores within the designated area. At least 200 spores per sample should be evaluated. If necessary, count two or more areas per spot. The results of spore viability are shown in Table IV. [Table 6]

[0138] Discussion: The spore viability immediately after preparation of the samples (day 1) is highly variable; in most cases the viability is greater than 50% and even in selected cases greater than 90%. Among the examples according to the invention, fluids are selected that show a spore viability of about 50% or more after about 3 months of storage at 30° C. (Table IV, entries 1, 10, 11, 15-17). In many cases, the spore viability in the selected fluids exceeds that of the Break-Thru S240 used as a control, i.e., about 20%, after about 3 months of storage at 30° C. Some liquids show poor spore viability under the conditions shown here.

Claims

1. 1. An essentially water-free liquid preparation comprising: At least one ethoxylated organic liquid, present in an amount of at least 40% by weight based on the total amount of the liquid formulation; and Fungal spores Including, the at least one ethoxylated organic liquid is an ethoxylated fatty acid triglyceride having from 3 to 10 ethylene oxide units, the ethoxylated fatty acid triglyceride being castor oil; The liquid preparation.

2. 2. The liquid formulation of claim 1, wherein the ethoxylated organic liquid is present in an amount of at least 50% by weight.

3. 3. A liquid preparation according to claim 1 or 2, which is water-miscible.

4. 4. The liquid preparation according to any one of claims 1 to 3, wherein the fungal spores are derived from fungal species effective as biological control agents or plant health promoters in plant protection.

5. The liquid preparation according to any one of claims 1 to 4, wherein the fungal species is an entomopathogenic fungus.

6. The liquid preparation according to any one of claims 1 to 4, wherein said fungal species is a nematicidally active fungus.

7. 7. The liquid preparation according to any one of claims 1 to 6, wherein the fungal species is selected from the group consisting of Isaria fumosorosea, Penicillium bilaii, Metalhizium anisopliae, Purpureocillium lilacinum, Coniothyrium minitans, Beauveria bassiana and Clonostachys rosea.

8. A liquid preparation according to any one of claims 1 to 7, further comprising at least one substance selected from the group of surfactants, rheology modifiers, antifoam agents, antioxidants and dyes.

9. 9. The liquid formulation of claim 8, wherein the rheology modifier is selected from the group consisting of fumed (hydrophobic / hydrophilic) or precipitated silica, naturally occurring silica, attapulgite-based rheology modifiers, organically modified clays, and mixtures thereof.

10. 10. The liquid formulation of claim 9, wherein the rheology modifier is fumed silica.

11. A liquid preparation according to any one of claims 1 to 10, comprising 0.1 to 40% by weight of fungal spores, up to 99.9% of at least one ethoxylated organic liquid according to any one of claims 1 to 10 and 0 to 10% by weight of at least one surfactant and / or rheology modifier.

12. A liquid composition comprising the liquid preparation according to any one of claims 1 to 11.

13. A method for controlling phytopathogenic fungi, insects and / or nematodes in or on a plant, for enhancing the growth of a plant or for increasing the yield or root health of a plant, said method comprising applying to said plant or to a locus where a plant is growing or intended to grow an effective amount of a liquid preparation according to any one of claims 1 to 11 or a liquid composition according to claim 12.

14. Use of a liquid preparation according to any one of claims 1 to 11 or a liquid composition according to claim 12 as a plant protection agent or for promoting plant vitality and / or plant health.

Citation Information

Patent Citations

  • Biocide composition containing alkoxylated oligoglycerol esters

    JP2013526492A

  • A composition substantially free of water and comprising at least one spore-forming fungal biocontrol agent, a polyether-modified trisiloxane and a fumed or precipitated silica

    JP2017534678A

  • Stable antimicrobial compositions including spore, bacteria, fungi, and / or enzyme

    US20060247150A1

  • Insecticidal oil-based formulations comprising an insecticidal filamentous fungus

    US20070141032A1

  • Stable aqueous spore-containing formulation

    US20110033436A1